InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Goodman Daniel Wintner, Director. Director active across 1 company, notably Tonix Pharmaceuticals Holding Corp.. Aggregated, 2 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €9k. History available since 25 May 2021. The latest transaction was filed on 25 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
5,000 shares@ US$1.120.0018% mcap50.0% of flowCommon StockSEC:0001387131-21-006089:0
Ideal exit: 19 Feb 2022 (T+270)
5,000 shares@ US$1.1250.0% of flowCommon StockSEC:0001387131-21-006089
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Goodman Daniel Wintner
Daniel Wintner Goodman is a Director at Tonix Pharmaceuticals Holding Corp. As a board member, he contributes to the strategy and governance of the company. His experience is valuable in guiding Tonix towards its objectives.
